Company intelligence / Profile preview

VetGen

Ann Arbor, Michigan, United States

Ownership: Private
Development stage: Other

Overview

VetGen provided highly accurate DNA tests for genetic diseases and traits in purebred animals, including dogs and horses. Tests helped breeders and owners avoid inherited disorders and make informed breeding decisions. The company closed permanently on June 21, 2023.

Therapeutic areas: OtherRare Diseases
Modalities: DNA test-based diagnostics
Industry: Veterinary

Partnerships

Collaborated broadly within veterinary and breeding communities; no major pharma/biotech partnerships identified

Beyond the preview

Go deeper on VetGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VetGen.

Explore the full profile